Richard Rauck, MD
Pain Medicine · Winston Salem, NCNPI 1205889938
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $263,058 of the $430,530 with a category attached, or 61.1%. 35 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 31.2% of the total. Among pain medicine clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 338 payments — averaging $1273.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$134K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$99K
- Boston Scientific$92K
- Biodelivery Sciences International, Inc.$25K
- Saluda Medical Americas, Inc.$19K
- Merck$15K
- plus $46K from 29 others
Across 271 payments — averaging $4686.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$407K
- Boston Scientific$234K
- Lexicon Pharmaceuticals, Inc.$108K
- Pfizer$99K
- Seikagaku Corporation$97K
- Regeneron$85K
- plus $241K from 14 others
What the payments were for
- Consulting fees$263,05861%
- Speaking & faculty fees$129,86830%
- Travel & lodging$29,8497%
- Food & beverage$7,7542%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 28 | $134,346 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 73 | $98,527 |
| Boston Scientific | 94 | $92,079 |
| Biodelivery Sciences International, Inc. | 28 | $24,802 |
| Saluda Medical Americas, Inc. | 18 | $19,309 |
| Merck | 19 | $15,106 |
| GRT US Holding, Inc. | 11 | $10,258 |
| Averitas Pharma Inc. | 6 | $9,500 |
| Vertex | 4 | $6,516 |
| Medtronic(2 entities) | 14 | $4,916 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $4,620 |
| Pacira Therapeutics, Inc. | 7 | $4,141 |
| Redhill Biopharma Inc. | 2 | $3,147 |
| Endo Pharmaceuticals Inc. | 2 | $2,160 |
| Pacira Pharmaceuticals Incorporated | 1 | $508 |
| SPR Therapeutics, Inc | 2 | $117 |
| Abbott | 3 | $74 |
| Nevro Corp. | 2 | $42 |
| Daiichi Sankyo Inc. | 3 | $41 |
| MML US, Inc. | 1 | $33 |
| Avanos Medical | 2 | $29 |
| Nalu Medical, Inc. | 1 | $28 |
| Vertiflex, Inc. | 1 | $27 |
| MDD US Operations, LLC | 2 | $24 |
| Spinal Simplicity, LLC | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $22 |
| Baudax Bio Inc. | 1 | $18 |
| Si-bone, Inc. | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $17 |
| Forte Bio-pharma LLC | 1 | $16 |
| Shionogi Inc | 1 | $14 |
| Pfizer | 3 | $14 |
| Sentynl Therapeutics, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RELISTOR$92,369
- BELBUCA$86,658
- XTAMPZA$66,430
- Nucynta$63,055
- CLINICAL TRIAL PRODUCT$59,562
- LUCEMYRA$22,315
- Qutenza$19,527
- PRECISION$13,375
- Evoke SCS$11,276
- SPECTRA WAVEWRITER$8,065
- Evoke$7,975
- WaveWriter Alpha Prime 16$7,697
- Zilretta$4,092
- MOVANTIK$3,120
- OPANA$2,070
- INTELLIS$1,254
- GENERAL PAIN MANAGEMENT$1,114
- SYNCHROMED$765
- GENERAL - THERAPIES$711
- EXPAREL$508
How this compares
$430,530 in reported general payments places this provider in the 95th percentile of 182 pain medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $450 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Winston Salem
- James NorthWinston Salem$721K
- Leonardo KapuralWinston Salem$523K
- Christopher GilmoreWinston Salem$457K
- Daniel BintrimWinston Salem$39K
- Jeffrey PeacockWinston Salem$13K
- Lauren BeaverWinston Salem$11K
- Courtney AumanJacksonville$186K
- Jacob WangCharlotte$162K
- Aashish KumarCharlotte$160K
- Javid BakshAsheville$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.